Details for New Drug Application (NDA): 202631
✉ Email this page to a colleague
The generic ingredient in DONEPEZIL HYDROCHLORIDE is donepezil hydrochloride. There are thirty-two drug master file entries for this compound. Thirty-eight suppliers are listed for this compound. Additional details are available on the donepezil hydrochloride profile page.
Summary for 202631
Tradename: | DONEPEZIL HYDROCHLORIDE |
Applicant: | Macleods Pharms Ltd |
Ingredient: | donepezil hydrochloride |
Patents: | 0 |
Pharmacology for NDA: 202631
Mechanism of Action | Cholinesterase Inhibitors |
Suppliers and Packaging for NDA: 202631
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
DONEPEZIL HYDROCHLORIDE | donepezil hydrochloride | TABLET;ORAL | 202631 | ANDA | Macleods Pharmaceuticals Limited | 33342-061 | 33342-061-07 | 30 TABLET, FILM COATED in 1 BOTTLE (33342-061-07) |
DONEPEZIL HYDROCHLORIDE | donepezil hydrochloride | TABLET;ORAL | 202631 | ANDA | Macleods Pharmaceuticals Limited | 33342-061 | 33342-061-10 | 90 TABLET, FILM COATED in 1 BOTTLE (33342-061-10) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 23MG | ||||
Approval Date: | Jan 22, 2014 | TE: | AB | RLD: | No |
Complete Access Available with Subscription